Vitamin D deficiency. Vitamin D deficiency
Conditions
Interventions
Intervention 1: Intervention Group 1: Patients in this group will receive one 50,000 IU vitamin D pearl (D-Vitin
manufactured by Zahravi Pharmaceutical Company) weekly for 8 weeks. Serum vitamin D levels will be remeasured at the end of the eighth week. Intervention 2: Intervention Group 2: Patients in this grou
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Being a medical student at Zahedan University of Medical Sciences. Aged between 18 and 30 years. Diagnosed with vitamin D deficiency, defined as a serum 25-hydroxyvitamin D level below 20 ng/mL. Willingness to participate and provision of signed informed consent. Not having taken any vitamin D or calcium supplements within the 3 months prior to the start of the study.
Exclusion criteria
Exclusion criteria: Presence of chronic diseases affecting vitamin D or calcium metabolism (e.g., renal or hepatic failure, hyperparathyroidism, sarcoidosis). Presence of malabsorption syndromes (e.g., celiac disease, Crohn's disease, ulcerative colitis). Use of medications known to interfere with vitamin D metabolism (e.g., anticonvulsants, systemic glucocorticoids, azole antifungals). History of hypercalcemia or calcium kidney stones. Pregnancy or lactation. Known hypersensitivity to vitamin D or any excipients in the study tablets. Unwillingness to continue cooperation or concurrent participation in another clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum vitamin D level. Timepoint: Measurement of serum vitamin D levels at baseline and at the end of the eighth week. Method of measurement: Based on the measurement of serum 25-hydroxyvitamin D levels in the laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum vitamin D level. Timepoint: Measurement of serum vitamin D levels at baseline and at the end of the eighth week. Method of measurement: Based on the measurement of serum 25-hydroxyvitamin D levels in the laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahpari Zafar Zamen
Zahedan University of Medical Sciences
Outcome results
None listed